Non-invasive imaging of CSF1R mAb biodistribution could provide information regarding physiological distribution and tumor targeting and thereby support the rational design of combination strategies that include macrophage targeting for breast cancer (19–21). This evidence concerns the gene CSF1R and breast carcinoma.